Ken Griffin's position in MBX Biosciences Common Stock is currently worth $40.1M. That's 0.03% of their equity portfolio (734th largest holding). The investor owns 2.78% of the outstanding MBX Biosciences Common Stock stock. The first MBX Biosciences Common Stock trade was made in Q3 2024. Since then Ken Griffin bought shares three more times and sold shares on two occasions. The stake costed the investor $14.7M, netting the investor a gain of 174% so far.